FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This... Read more
Sutro Biopharma
3 followers
Active Motif
3 followers
Xeris Pharmaceuticals
3 followers
AbbVie
294 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Amgen
302 followers
Elanco
28 followers
Eikon Therapeutics
3 followers
Cosette Pharmaceuticals
1 follower
Bristol-Myers Squibb
275 followers
Explore companies